{"brief_title": "A Study of Lobucavir in Patients With AIDS", "brief_summary": "The purpose of this study is to see if lobucavir is a safe and effective treatment for cytomegalovirus in patients with AIDS.", "detailed_description": "Patients receive 1 of 2 doses of lobucavir for 28 days, with 2 weeks of follow-up. Weekly clinic visits are required.", "condition": ["Cytomegalovirus Infections", "HIV Infections"], "intervention_type": ["Drug"], "intervention_name": ["Lobucavir"], "criteria": "Inclusion Criteria Concurrent Medication: Allowed: - Aerosolized pentamidine. - TMP / SMX. - Isoniazid. - Dapsone. - Fluconazole. - Ketoconazole. - Rifabutin. - Fluoxetine HCl. - Acetaminophen. - Antacids. - Metamucil. - Multivitamins. - Other drugs with approval from sponsor. Patients must have: - AIDS. - CD4 count < 200 cells/mm3. - Cytomegalovirus ( CMV ) viruria and virosemenia. - No evidence of intraocular CMV. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Acute or chronic cardiovascular, pulmonary, renal, hepatic, pancreatic, hematologic, endocrine, neurological, or other unstable illness. - Inability to take oral medication. - Allergy to nucleoside analogs. - Diarrheal illness. - Poor venous access. - Positive test for drugs of abuse. - Any other condition that would render patient unsuitable for study. Patients with the following prior conditions are excluded: - History of pancreatitis. - Recent diarrheal illness. - History of weight loss. - Acute serious illness within 4 weeks prior to study entry. Prior Medication: Excluded within 4 weeks prior to study entry: - Erythropoietin. - Any agent with anti-CMV activity. - Other investigational agents. Prior Treatment: Excluded within 4 weeks prior to study entry: - Surgery. - Blood transfusion. Drug abuse.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Antiviral Agents", "mesh_term": ["Infection", "Communicable Diseases", "HIV Infections", "Cytomegalovirus Infections", "Lobucavir"], "id": "NCT00002352"}